Hosted on MSN
Cough syrup deaths: CDSCO starts risk-based inspection at manufacturing units in 6 states
New Delhi | Central drug regulator CDSCO has initiated risk-based inspection of drug manufacturing units in six states following collection of 19 samples including that of cough syrups, antipyretics ...
CHHINDWARA/NEW DELHI, India (Reuters) -India has refused drugmakers' requests to extend a year-end deadline for them to upgrade their manufacturing facilities to international standards, four sources ...
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results